原位肝移植治疗肝脏上皮样血管内皮瘤（附2例报告及文献复习）

张全保; 陶一峰; 李瑞东; 邹丽萍; 马震宇; 张晓飞; 王正昕

doi:10.3969/j.issn.1674-7445.2017.01.012

原位肝移植治疗肝脏上皮样血管内皮瘤（附2例报告及文献复习）

doi: 10.3969/j.issn.1674-7445.2017.01.012

200040 上海，复旦大学附属华山医院普外科肝移植中心（张全保、陶一峰、李瑞东、马震宇、张晓飞、王正昕）；病理科（邹丽萍）

基金项目:

国家自然科学基金面上项目 81270551

详细信息

通讯作者:
王正昕，Email：778622916@qq.com

中图分类号: R617, R735.7
计量
- 文章访问数: 227
- HTML全文浏览量: 45
- PDF下载量: 8
- 被引次数: 0
出版历程
- 收稿日期: 2016-09-20
- 网络出版日期: 2021-01-19
- 刊出日期: 2017-01-15

Orthotopic liver transplantation for treatment of hepatic epithelioid hemangioendothelioma: report of two cases and literature review

Department of General Surgery, Liver Transplantation Center, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China

More Information

Corresponding author: Wang Zhengxin, Email:778622916@qq.com

摘要

摘要: 目的探讨原位肝移植治疗肝脏上皮样血管内皮瘤（EHE）的疗效及相关治疗进展。方法回顾性分析2例肝脏EHE患者的临床资料。例1为肝脏广泛多发EHE合并脾脏多发梗死灶的患者，实施了原位肝移植+脾切除术；例2为肝脏多发EHE患者，仅实施了原位肝移植。结合国内外文献，分析肝脏EHE患者的病理学特点、肝移植治疗及预后情况。结果两例患者手术过程顺利，均康复出院。病理结果证实为肝脏EHE，例1合并脾脏EHE。例1术后1个月抗排斥反应药由他克莫司换为西罗莫司，术后4个月EHE复发，给予卡培他滨口服化学药物治疗（化疗）；术后6个月考虑肝脏EHE复发并多发性骨转移，予索拉非尼口服抗肿瘤治疗，术后7个月患者死于恶病质、肝衰竭。例2随访至投稿日（术后8个月），未见术后相关并发症及肿瘤复发迹象。国内外文献报道提示肝脏EHE首选手术切除，肝内广泛多发而无法手术切除者，甚至有肝外病灶者，肝移植疗效最佳。另外，化疗、经皮穿刺肝动脉化疗栓塞和抗血管生成治疗对本病也有一定疗效。结论肝脏EHE治疗首选手术切除，对于肝内广泛多发者，肝移植被认为是最佳的治疗选择。应重视肝脏EHE移植术后复发的防治，以期进一步提高该病的疗效。
- 上皮样血管内皮瘤, 肝脏 /
- 肝肿瘤 /
- 原位肝移植 /
- 预后 /
Abstract: Objective To investigate the clinical efficacy and therapeutic progress of orthotopic liver transplantation for the treatment of hepatic epithelioid hemangioendothelioma (EHE). Methods Clinical data of 2 patients diagnosed with hepatic EHE were retrospectively analyzed. One patient (case 1) was diagnosed with multiple hepatic EHE complicated with multiple infarction lesions of the spleen, and underwent orthotopic liver transplantation combined with splenectomy. The other case (case 2) was diagnosed with multiple hepatic EHE and received orthotopic liver transplantation alone. Literature review was performed. Pathological characteristics, clinical efficacy of liver transplantation and clinical prognosis of hepatic EHE patients were analyzed. Results Two patients successfully underwent surgery and were discharged postoperatively. The diagnosis of hepatic EHE was confirmed by pathological examination and case 1 was complicated with EHE of the spleen. For case 1, tacrolimus was replaced by sirolimus at postoperative 1 month. At postoperative 4 months, capecitabine was orally administered (chemotherapy) for EHE recurrence. At 6 months after surgery, the patient was diagnosed with recurrent hepatic EHE complicated with multiple bone metastases, and was orally administered with sorafenib. At postoperative 7 months, the patient died from cachexia and liver failure. Case 2 was followed up until the submission date (8 months after surgery). No postoperative complications and tumor recurrence were observed. Previous studies had demonstrated that surgical resection was the primary therapy of hepatic EHE. Liver transplantation was highly recommended for patients with multiple unresectable hepatic EHE and extra-hepatic lesions. Moreover, chemotherapy, percutaneous puncture combined with transcatheter arterial chemoembolization and anti-angiogenesis treatment exerted certain clinical efficacy. Conclusions Surgical resection remains the primary therapy of hepatic EHE. For patients with multiple intrahepatic EHE, liver transplantation is considered as the optimal treatment. Much attention should be diverted to the prevention and treatment of recurrent hepatic EHE following liver transplantation, aiming to improve the clinical efficacy.
- Epithelioid hemangioendothelioma /
- Liver /
- Hepatic tumor /
- Orthotopic liver transplantation /
- Prognosis

HTML全文

图 1 肝移植治疗肝脏EHE的病理及影像学图片（例1）

A图为全肝切除标本，肝脏明显肿大，大小30 cm×24 cm×9 cm，质量3 640 g，表面见弥漫状灰褐灰黄色改变；B图为脾切除标本，大小27 cm×16 cm×7 cm，切面见楔形黄色梗死灶多处，直径1~10 cm；C图为术前MRI的T₂W₁相，可见肝脏弥漫分布的0.5~3.0 cm大小不等的高信号病灶；D图为术前增强MRI门静脉期，示病灶中央和边缘低信号，其间夹杂环形高信号强化带，呈典型“晕圈”（箭头所示）；E图为肝组织免疫组化染色示CD31（+）（LSAB，×200）；F图为肝组织免疫组化染色示CD34（+）（LSAB，×200）；G图为术后6个月增强MRI静脉期，示移植肝多发强化病灶，多个病灶呈环形强化；H图为术后6个月胸部CT平扫，示胸骨、肋骨、胸椎骨、肩胛骨、肱骨头骨质破坏

Figure 1. Pathology and radiology images of a patient with hepatic EHE treated by liver transplantation (case 1)

下载: 全尺寸图片幻灯片

参考文献(30)

[1]	Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma[J]. Cancer, 1982, 50(5): 970-981. doi: 10.1002/(ISSN)1097-0142
[2]	Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition[J]. Pathology, 2014, 46(2): 95-104. DOI: 10.1097/PAT.0000000000000050.
[3]	Ishak KG, Sesterhenn IA, Goodman ZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases[J]. Hum Pathol, 1984, 15(9): 839-852. doi: 10.1016/S0046-8177(84)80145-8
[4]	Rude MK, Watson R, Crippin JS. Recurrent hepatic epithelioid hemangioendothelioma after orthotopic liver transplantation[J]. Hepatology, 2014, 59(5): 2050-2052. DOI: 10.1002/hep.26891.
[5]	Lerut JP, Orlando G, Adam R, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry[J]. Ann Surg, 2007, 246(6): 949-957. doi: 10.1097/SLA.0b013e31815c2a70
[6]	Rodriguez JA, Becker NS, O'Mahony CA, et al. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005[J]. J Gastrointest Surg, 2008, 12(1): 110-116. doi: 10.1007/s11605-007-0247-3
[7]	孙淑杰, 迮兴宇, 赵新颜, 等.肝上皮样血管内皮瘤文献复习及临床特点分析[J].临床和实验医学杂志, 2012, 11(9): 654-656.DOI: 10.3969/j.issn.1671-4695.2012.09.006.Sun SJ, Ze XY, Zhao XY, et al. A review of literatures on clinical manifestations of hepatic epithelioid hemagioendothelioma[J]. J Clin Exp Med, 2012, 11(9): 654-656.DOI: 10.3969/j.issn.1671-4695.2012.09.006.
[8]	Grotz TE, Nagorney D, Donohue J, et al. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?[J]. HPB, 2010, 12(8): 546-553. DOI: 10.1111/j.1477-2574.2010.00213.x.
[9]	Otrock ZK, Al-Kutoubi A, Kattar MM, et al. Spontaneous complete regression of hepatic epithelioid haemangioendothelioma[J]. Lancet Oncol, 2006, 7(5): 439-441. doi: 10.1016/S1470-2045(06)70697-0
[10]	康锶鹏, 谢飞来, 郑智勇.肝脏上皮样血管内皮细胞瘤1例[J].世界华人消化杂志, 2015, 23(19): 3166-3170. DOI: 10.11569/wcjd.v23.i19.3166. Kang SP, Xie FL, Zheng ZY. Hepatic epithelioid haemangioendothelioma: report of one case[J]. World J Chin Dig, 2015, 23(19): 3166-3170. DOI: 10.11569/wcjd.v23.i19.3166.
[11]	张树辉, 丛文铭, 吴孟超, 等.肝上皮样血管内皮瘤的临床病理特点(附8例报告及文献复习)[J].中华肝胆外科杂志, 2003, 9(6): 327-330. DOI: 10.3760/cma.j.issn.1007-8118.2003.06.004. Zhang SH, Cong WM, Wu MC, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathological study on 8 cases and review of literature[J]. Chin J Hepatobiliary Surg, 2003, 9(6): 327-330. DOI: 10.3760/cma.j.issn.1007-8118.2003.06.004.
[12]	Sardaro A, Bardoscia L, Petruzzelli MF, et al. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor[J]. Oncol Rev, 2014, 8(2): 259. DOI: 10.4081/oncol.2014.259.
[13]	Errani C, Zhang L, Sung YS, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites[J]. Genes Chromosomes Cancer, 2011, 50(8): 644-653. DOI: 10.1002/gcc.20886.
[14]	Antonescu CR, Le Loarer F, Mosquera JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma[J]. Genes Chromosomes Cancer, 2013, 52(8): 775-784. DOI: 10.1002/gcc.22073.
[15]	Mascarelli PE, Iredell JR, Maggi RG, et al. Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma[J]. J Clin Microbiol, 2011, 49(11): 4006-4012. DOI: 10.1128/JCM.05527-11.
[16]	陈漪.肝上皮样血管内皮瘤的诊断与鉴别诊断[J].实用肝脏病杂志, 2013, 16(5): 398-400. DOI: 10.3969/j.issn.1672-5069.2013.05.005. Chen Y. The diagnosis and differential diagnosis of hepatic epithelioid hemangioendothelioma[J]. J Clin Hepatol, 2013, 16(5): 398-400. DOI: 10.3969/j.issn.1672-5069.2013.05.005.
[17]	周丽莎, 翟凤仪, 董帜, 等.肝脏上皮样血管内皮瘤的CT和MRI表现[J].临床放射学杂志, 2015, 34(3): 402-405. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201503022.htm Zhou LS, Zhai FY, Dong Z, et al. CT and MRI features of hepatic epithelioid hemangioendotheliomas[J]. J Clin Radiol, 2015, 34(3): 402-405. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201503022.htm
[18]	吕鹏, 林江, 周易, 等.肝脏上皮样血管内皮瘤:影像表现和病理基础[J].中国医学计算机成像杂志, 2011, 17(5): 416-419. DOI: 10.3969/j.issn. 1006-5741.2011.05.007. Lyu P, Lin J, Zhou Y, et al. Hepatic epithelioid hemangioendothelioma: imaging and pathologic findings[J]. Chin Comp Med Imag, 2011, 17(5): 416-419.DOI: 10.3969/j.issn.1006-5741.2011.05.007.
[19]	Yousaf N, Maruzzo M, Judson I, et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience[J]. Anticancer Res, 2015, 35(1): 473-480. http://ar.iiarjournals.org/content/35/1/473.full
[20]	Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy[J]. Cancer, 2006, 107(9): 2108-2121. doi: 10.1002/(ISSN)1097-0142
[21]	Nudo CG, Yoshida EM, Bain VG, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience[J]. Can J Gastroenterol, 2008, 22(10): 821-824. doi: 10.1155/2008/418485
[22]	孙雁.肝脏上皮样血管内皮瘤行肝移植术的治疗体会[J].天津医药, 2009, 37(11): 983-984. DOI: 10.3969/j.issn.0253-9896.2009.11.032. Sun Y. Experience in the treatment of liver transplantation for hepatic epithelioid hemangioendothelioma[J]. Tianjin Med J, 2009, 37(11): 983-984. DOI: 10.3969/j.issn.0253-9896.2009.11.032.
[23]	周健鞠, 卫强, 何晓顺, 等.肝移植治疗肝脏上皮样血管内皮瘤2例报告并文献复习[J/CD].中华普通外科学文献(电子版), 2012, 6(4): 318-321. DOI: 10.3877/cma.j.issn.1674-0793.2012.04.009. Zhou JJ, Wei Q, He XS, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: report of two cases and review of the literature[J/CD]. Chin Arch Gen Surg (Electr Edit), 2012, 6(4): 318-321.DOI: 10.3877/cma.j.issn.1674-0793.2012.04.009.
[24]	Demir L, Can A, Oztop R, et al. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and interferon treatment: a case presentation and a brief review of the literature[J]. J Cancer Res Ther, 2013, 9(1): 125-127. DOI: 10.4103/0973-1482.110386.
[25]	St Peter SD, Moss AA, Huettl EA, et al. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma[J]. Clin Transplant, 2003, 17(6): 549-553. doi: 10.1046/j.1399-0012.2003.00055.x
[26]	Wang LR, Zhou JM, Zhao YM, et al. Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients[J]. World J Surg, 2012, 36(11): 2677-2683. DOI: 10.1007/s00268-012-1714-x.
[27]	Salech F, Valderrama S, Nervi B, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with along term follow-up[J]. Ann Hepatol, 2011, 10(1): 99-102.
[28]	Pallotti MC, Nannini M, Agostinelli C, et al. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma[J]. World J Gastroenterol, 2014, 20(22): 7049-7054. DOI: 10.3748/wjg.v20.i22.7049.
[29]	Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase Ⅱ study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas[J]. Ann Oncol, 2013, 24(1): 257-263. DOI: 10.1093/annonc/mds237.
[30]	Chevreau C, Le Cesne A, Ray-Coquard I, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO)[J]. Cancer, 2013, 119(14): 2639-2644. DOI: 10.1002/cncr.28109.